We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Cytokinetics
CYTK
$11B
| $475K | 0.01% |
70,746
-45,500
| -39% | -$298K |
|
577
Live Nation Entertainment
LYV
$41.2B
| $474K | 0.01% |
17,235
-100,575
| -85% | -$2.75M |
|
578
Alnylam Pharmaceuticals
ALNY
$36.3B
| $472K | 0.01% |
3,940
-3,500
| -47% | -$418K |
|
|
LEAF
579
DELISTED
Leaf Group Ltd.
LEAF
| $470K | 0.01% |
73,856
+56,639
| +329% | +$335K |
|
|
ALSK
580
DELISTED
Alaska Communications Systems
ALSK
| $467K | 0.01% |
194,452
+105,585
| +119% | +$237K |
|
|
CPLA
581
DELISTED
Capella Education Company
CPLA
| $466K | 0.01% |
8,675
| – | – |
|
|
DTLK
582
DELISTED
Datalink Corp
DTLK
| $466K | 0.01% |
52,131
+39,125
| +301% | +$401K |
|
|
SGBK
583
DELISTED
Stonegate Bank
SGBK
| $463K | 0.01% |
15,620
-100
| -0.6% | -$2.96K |
|
|
CYBX
584
DELISTED
CYBERONICS INC
CYBX
| $462K | 0.01% |
7,770
-4,100
| -35% | -$258K |
|
585
Alkermes
ALKS
$8.82B
| $459K | 0.01% |
7,140
-7,660
| -52% | -$469K |
|
586
Goldman Sachs
GS
$313B
| $451K | 0.01% |
2,160
-1,770
| -45% | -$361K |
|
587
Woodward
WWD
$25B
| $447K | 0.01% |
8,120
-450
| -5% | -$23.1K |
|
|
MRGE
588
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $442K | 0.01% |
92,114
-35,600
| -28% | -$170K |
|
589
Bank OZK
OZK
$5.49B
| $438K | 0.01% |
9,570
-15,325
| -62% | -$652K |
|
590
Telephone and Data Systems
TDS
$3.91B
| $438K | 0.01% |
+14,910
| New | +$428K |
|
|
KEM
591
DELISTED
KEMET Corporation
KEM
| $432K | 0.01% |
149,891
+18,220
| +14% | +$66.9K |
|
592
American Superconductor
AMSC
$1.48B
| $429K | 0.01% |
82,017
+15,820
| +24% | +$104K |
|
593
Cimpress
CMPR
$2.37B
| $428K | 0.01% |
+5,080
| New | +$434K |
|
|
GIFI
594
DELISTED
Gulf Island Fabrication
GIFI
| $428K | 0.01% |
38,344
-4,970
| -11% | -$63.3K |
|
|
QEP
595
DELISTED
QEP RESOURCES, INC.
QEP
| $427K | 0.01% |
+23,060
| New | +$473K |
|
|
SCMP
596
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $424K | 0.01% |
25,793
-5,400
| -17% | -$93.6K |
|
597
Pediatrix Medical
MD
$2.16B
| $422K | 0.01% |
5,700
-6,300
| -53% | -$453K |
|
598
SLM Corp
SLM
$4.57B
| $420K | 0.01% |
+42,600
| New | +$431K |
|
|
KONA
599
DELISTED
Kona Grill, Inc.
KONA
| $416K | 0.01% |
21,430
-8,600
| -29% | -$195K |
|
600
Ezcorp Inc
EZPW
$1.82B
| $414K | 0.01% |
55,701
+25,501
| +84% | +$218K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.